InterPharm Investments Ltd is a UK company established to develop patent-protected products which can be developed and brought to market as medical foods, dietary supplements or medical devices. InterPharm’s product portfolio presently includes licensed-in products, sold through its affiliates or subsidiary companies in local markets, starting with InterAlia srl in Italy. InterPharm's own products will be out-licensed in major markets worldwide.
InterPharm has acquired the European rights to the FacetoFaceMeeting video conferencing application from Arizona-based Clinical Information Network Inc. InterPharm will incorporate Clinical Information Network Europe Ltd, a new company, to provide products and services to pharma companies across Europe based on this proprietary software. InterPharm will use the software to launch and promote its own products.
Company Details
- Founded
- -
- Address
- Office 8001 - 21 Effie Road, Fulham Broadway,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- interpharminvestments.com
- HQ
- London
Interpharm Investments Limited Questions
Interpharm Investments Limited's website is interpharminvestments.com
Interpharm Investments Limited's LinkedIn profile is https://uk.linkedin.com/company/interpharm-investments-limited
Interpharm Investments Limited's industry is
Pharmaceutical Manufacturing
Interpharm Investments Limited's top competitors are
Dbk Pharma,
Ethsg,
Deluge Pharm,
Interpharma Co.,
Nanomotion,
Interlab Development,
Interpharm,
Mileutis Ltd.,
One Pharma Medics,
Interpharm Del Ecuador.
Interpharm Investments Limited's categories are Pharmaceutical Manufacturing
Interpharm Investments Limited's founding year is 2009
